(Q37952079)

25 August 2017

title

Endophthalmitis following intravitreal injections (English)

1 reference

25 August 2017

2

Kimia Ziahosseini

1 reference

25 August 2017

Cristina Irigoyen

1

1 reference

25 August 2017

George Morphis

series ordinal

3

1 reference

25 August 2017

Theodor Stappler

series ordinal

4

1 reference

25 August 2017

Heinrich Heimann

series ordinal

5

1 reference

25 August 2017

publication date

3 November 2011

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

25 August 2017

published in

1 reference

25 August 2017

volume

250

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

499-505

1 reference

Pegaptanib for neovascular age-related macular degeneration

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Toxic vitreitis outbreak after intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Severe intraocular inflammation after intravitreal injection of bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Distinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Short-term complications of intravitreal injections of triamcinolone and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Microbiological properties of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Endophthalmitis: gram positive ethiological agents and susceptibility to glycopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Endophthalmitis after intravitreal injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Complications of intravitreal injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

A cluster of acute-onset postoperative endophthalmitis over a 1-month period: investigation of an outbreak caused by uncommon species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-011-1851-1

Case of endophthalmitis following intravitreal injections of bevacizumab

21 January 2018

1 reference

12 December 2020

Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group

1 reference

12 December 2020

Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration.

1 reference

12 December 2020

Ten years after... are findings of the Endophthalmitis Vitrectomy Study still relevant today?

1 reference

12 December 2020

Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study

1 reference

12 December 2020

10.1007/S00417-011-1851-1

Identifiers

DOI

1 reference

25 August 2017

1 reference